Active ingredients: bivalirudin
What it is used for
DBL Bivalirudin Powder for Injection is indicated for use as an anticoagulant: in the treatment of patients with moderate to high risk acute coronary syndromes (ACS) (unstable angina/non-ST segment elevation myocardial infarction (UA/NSTEMI) who are undergoing early invasive management, and in patients undergoing percutaneous coronary intervention (PCI).,DBL Bivalirudin Powder for Injection intended for use with aspirin.,A P2Y12 antagonist (e.g. clopidogrel or ticlopidine) may be used in addition to aspirin.
How to take it
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
White lyophilised cake, supplied sterile in a type I glass vial with chlorobutyl rubber stoppers and aluminium seal with a flip-off cap.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient bivalirudin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems